Tangtangquan (Online Patient Education Service)

We provide an app-based all-around care for people with type 1 diabetes that is currently the most widely used blood glucose management application in Chinese mainland.

By

Shenzhen Aibaowei Biotechnology CO., LTD.

This is member exclusive
content. Click here to unlock

Social causes

Beneficiaries

SDGs covered

Market of Implementation

  • China

Problem

Type 1 diabetes is a lifelong disease and can not be cured for now. Low patient compliance and low glucose management efficiency are the problems encountered.

Solution

More than 60 percent of our users are from undeveloped areas in China, and it indicates that through mobile internet method, the people in poverty areas can also receive good medical resources. We develop a “peer support” system and a doctor follow-up system that let the people in remote areas get help from the patient leader and doctor for free when needed.

Unlock this content

This is member exclusive content. Join us as an AVPN member and unlock more insightful content

Stay updated. Sign up for the #1 newsletter on social investment in Asia.

This field is for validation purposes and should be left unchanged.

©2021 Asian Venture Philanthropy Network | AVPN is registered in Singapore as a charity (UEN 201016116M)